Zilebesiran: A novel RNA interference therapeutic for hypertension
1. 系统已在2026-03-31 16:35:39对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接:
其他信息:
D Maheta, F Shah, V Biba, NN Ngardig…
Cardiology in …, 2025
journals.lww.com
Hypertension remains a leading modifiable risk factor for cardiovascular morbidity and mortality, yet blood pressure control rates are suboptimal, partly due to adherence challenges with daily medications. Zilebesiran is an investigational small interfering RNA therapy targeting hepatic angiotensinogen synthesis to achieve prolonged suppression of the renin–angiotensin–aldosterone system. By conjugating the small interfering RNA to N-acetylgalactosamine, zilebesiran is delivered specifically to hepatocytes, leading to> 90 …
